Target intelligence / Profile preview

Influenza A virus matrix protein M1 (M1)

Target
M1
Molecular classification
Other (viral matrix protein)
01

Overview

The Influenza A virus matrix protein M1 is the most abundant structural protein in the virus, forming a helical matrix layer beneath the viral envelope that maintains virion integrity and supports interactions with the cytoplasmic tails of hemagglutinin (HA) and neuraminidase (NA) as well as viral ribonucleoproteins (vRNPs). Structurally, it consists of an N-terminal domain (NTD) rich in alpha-helices and a flexible C-terminal domain (CTD) that enables oligomerization into single- or multi-layered helical assemblies, with pH-dependent conformational changes critical for uncoating during cell entry. M1 plays multifaceted roles across the viral lifecycle, including facilitating endosomal disassembly via host factors like HDAC6, suppressing viral mRNA transcription in the nucleus, promoting vRNP nuclear export, and driving membrane curvature for assembly and budding at the plasma membrane. Its conservation, especially in key residues for pH sensing and interactions, underscores its essentiality for viral replication, transmissibility, and pathogenicity in influenza A infections across avian and mammalian hosts. These properties position M1 as a promising antiviral target, though specific inhibitors remain underdeveloped.

Other names
Matrix protein 1
02

Biological functions

Viral uncoatingPolymerase activity regulationvRNA transcription and replicationNuclear export of vRNPVirus assembly and buddingVirion morphogenesis
03

Disease associations

Infection

Beyond the preview

Go deeper on Influenza A virus matrix protein M1 (M1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus matrix protein M1 (M1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call